DJIA 16,982.59 22.02 0.13%
NASDAQ 4,444.91 0.00 0.00%
S&P 500 1,978.91 0.57 0.03%
market minute promo

8.91 -0.19 (-2.09%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

HALO $8.91 -2.09%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $9.13
Previous Close $9.10
Daily Range $8.79 - $9.19
52-Week Range $6.51 - $18.18
Market Cap $1.1B
P/E Ratio -11.52
Dividend (Yield) $0.00 (0.0%)
Volume 961,645
Average Daily Volume 1,322,314
Current FY EPS -$0.68

Sector

Healthcare

Industry

Drugs

Halozyme Therapeutics, Inc. (HALO) Description

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets. Website: http://www.halozyme.com/

News & Commentary

Why Halozyme Therapeutics Inc., Omeros Corp., and Fluidigm Corp. Jumped Today

The Fed's taper sent the stock market soaring, but news pushed many stocks up even more sharply, as Halozyme climbed 17%, Omeros gained 18%, and Fluidigm rose 14%. Find out more about what helped these stocks soar.

Halozyme Announces Resumption of Patient Enrollment, Dosing in PEGPH20 Clinical Trial

Trade-Ideas: Halozyme Therapeutics (HALO) Is Today's "Perilous Reversal" Stock

4 Key Positive Biotech Stock Catalysts Coming Very Soon

12 Analyst Stocks to Buy Under $10 With Massive Upside Potential

Benzinga's Top Initiations

JP Morgan Initiates Halozyme Therapeutics With Outperform

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatm

Halozyme Attracting Attention With Upcoming Adcom And Potential Blockbuster Pancreatic Cancer Treatment

2nd Half Of 2014 Biotechnology Catalysts - Part 2

Benzinga's Top #PreMarket Gainers

Twelve Analyst Stocks Trading Under $10 With Huge Implied Upside

See More HALO News...

HALO's Top Competitors

HALO $8.91 (-2.09%)
Current stock: HALO
AMGN $122.65 (-0.15%)
Current stock: AMGN
GILD $91.46 (1.80%)
Current stock: GILD
BIIB $336.39 (0.28%)
Current stock: BIIB